LONDON, July 4, 2018 /PRNewswire/ --
PharmaBoardroom today releases its new 26-page report, 'Healthcare & Life Sciences Review: Medical Cannabis in Canada'
With cannabis and cannabinoid treatments increasingly becoming accepted as legitimate and effective medicines for a wide variety of conditions
A number of Canadian companies now stand at the forefront of this massive global growth industry, leveraging the demand for cannabis and cannabinoid products at home and increasingly establishing positions as global leaders. Through the exclusive insights of the Canadian medical cannabis industry's leading executives, this report explores how companies are navigating the regulatory environment is what is still a young sector; which organizations are taking their cues from the more mature biotech industry to develop clinical trials or partner with pharma companies; how massive funding injections are being secured via public listings; and how Canadian companies are leveraging their homegrown expertise to take their products and services to medical cannabis hotspots around the globe.
Interviews and Features
The report features the comments of:
"We have a regulator in Health Canada that is becoming increasingly focused on opening up new channels for cannabis research." - Marc Wayne, Canopy Health
"We can definitely sense that we are on the verge of disruption in the medical cannabis industry." - Bernard Fortier, Tetra Bio-Pharma
"Our NASDAQ listing demonstrates that the industry has matured. It is important for us that institutional investors and the pharmaceutical community recognize how far the industry has come." - Michael Gorenstein, The Cronos Group
"It is not every day that you get to participate in building an entire industry. In this space, nothing is set in stone yet; everything is new and has to be developed. Times are exciting and being part of it is thoroughly thrilling!" - Greg Engel, Organigram
Click here to register and download the report.
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All